clinical pathways

Research in Review

Clinical Pathway Encourages Adherence to National Guidelines for Febrile Neutropenia

10/12/2016

JCP Editors

Clinical pathways developed in accordance with national guidelines can improve adherence to recommendations regarding the use of empiric vancomycin in patients with febrile neutropenia (FN), according to a study...

...

10/12/2016

Journal of Clinical Pathways

Research in Review

Evidence-Based Clinical Pathways to Improve Anesthetic Outcomes in Bariatric Surgery

10/12/2016

JCP Editors

Studies have assessed the feasibility of fast-track surgery in patients undergoing bariatric surgery. However, findings from a recent study published in Obesity Surgery showed that the degree of obesity influences...

...

10/12/2016

Journal of Clinical Pathways

Department

Integrating Precision Medicine Into Chronic Lymphocytic Leukemia Pathways

09/21/2016

JCP Editors

“It is time to rethink how we treat chronic lymphocytic leukemia (CLL),” said Chadi Nabhan, MD, MBA, FACP, Cardinal Health Specialty Solutions (Chicago, IL) during a session at the Clinical Pathways Congress, where...

“It is...

09/21/2016

Journal of Clinical Pathways

Department

The End of Clinical Pathways?

09/19/2016

JCP Editors

In a presentation at the inaugural Clinical Pathways Congress, Michael Kolodziej, MD, national medical director, Managed Care Strategy, Flatiron Health, argued that clinical pathways as we know them will cease to...

In a...

09/19/2016

Journal of Clinical Pathways

Viewpoint

The Limitations of Patient-Reported Outcome Measurement in Oncology

09/06/2016

Stephen P McKenna, PhD, AFBPsS, CPsychol

Generic patient-reported outcome measures (PROMs) for cancer have outlived their utility. More relevant and accurate PROMs are required in order to demonstrate the true value of oncology interventions to...

...

09/06/2016

Journal of Clinical Pathways

Clinical Pathways GPS

Impact of Quality of Life on Clinical Pathways

08/02/2016

Jill Cantelmo, DPhil, MSc

Seth Gordon, MBA

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

For clinical pathway developers seeking to define the value of different treatments, quality-of-life (QOL) measures offer a means of capturing the factors that most define value to the patient and their caregivers....

For...

08/02/2016

Journal of Clinical Pathways

Conference Coverage

American Society of Clinical Oncology Annual Meeting

08/02/2016

JCP Editors

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, a session was held on the first day dedicated to the topic of clinical pathways in oncology. The session, titled “Practicing in the Age of...

At the...

08/02/2016

Journal of Clinical Pathways

Corrigendum

Corrigendum: Could the Lack of an Efficient and Affordable Diagnostic Pathway Limit Market Access for New Alzheimer`s Treatments?

08/02/2016

Rick Lifsitz, MBA

Larry Blandford, PharmD—Column Editor

In the June 2016 article, “Could the Lack of an Efficient and Affordable Diagnostic Pathway Limit Market Access for New Alzheimer’s Treatments?"1 the author and column editor would like to clarify several points....

In the...

08/02/2016

Journal of Clinical Pathways

Editor's Page

Can Value Frameworks Effect Real Change in Health Care?

08/02/2016

Winston Wong, PharmD, Editor-in-Chief

The concept of value in health care has become increasingly important, and this is unlikely to change any time soon. Health care reforms have been proposed in order to slow the increase in health care costs while...

The...

08/02/2016

Journal of Clinical Pathways

Research in Review

Bundled Payments Model Utilizing Clinical Pathways a Success for Hip and Knee Replacements

06/20/2016

JCP Editors

A Bundled Payments for Care Improvement model developed at New York University Langone Medical Center (NYULMC), New York City, NY, was successful at improving institutional efficiency and providing more value...

...

06/20/2016

Journal of Clinical Pathways